CMU Intellectual Repository: Browsing DSpace

Browsing by Author Virote Sriuranpong

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:

Showing results 1 to 5 of 5

Issue Date	Title	Author(s)
20-Jul-2011	Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non - small-cell lung cancer in Asia (IPASS)	Masahiro Fukuoka; Yi Long Wu; Sumitra Thongprasert; Patrapim Sunpaweravong; Swan Swan Leong; Virote Sriuranpong; Tsu Yi Chao; Kazuhiko Nakagawa; Da Tong Chu; Nagahiro Saijo
15-Jul-2015	Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy	Tony Mok; Yi Long Wu; Jin Soo Lee; Chong Jen Yu; Virote Sriuranpong; Jennifer Sandoval-Tan; Guia Ladrera; Sumitra Thongprasert; Vichien Srimuninnimit; Meilin Liao; Yunzhong Zhu; Caicun Zhou; Fatima Fuerte; Benjamin Margono; Wei Wen; Julie Tsai; Matt Truman; Barbara Klughammer; David S. Shames; Lin Wu
1-Jun-2011	Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trial	Tony S K Mok; Te Chun Hsia; Chun Ming Tsai; Kenneth Tsang; Gee Chen Chang; John Wen Cheng Chang; Sirisinha Thitiya; Virote Sriuranpong; Sumitra Thongprasert; Daniel Tt Chua; Nicola Moore; Christian Manegold
1-Jan-2018	Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset	Byoung Chul Cho; Busayamas Chewaskulyong; Ki Hyeong Lee; Arunee Dechaphunkul; Virote Sriuranpong; Fumio Imamura; Naoyuki Nogami; Takayasu Kurata; Isamu Okamoto; Caicun Zhou; Ying Cheng; Eun Kyung Cho; Pei Jye Voon; Jong Seok Lee; Helen Mann; Matilde Saggese; Thanyanan Reungwetwattana; Suresh S. Ramalingam; Yuichiro Ohe
1-Aug-2016	Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer	Tony Mok; Guia Ladrera; Vichien Srimuninnimit; Virote Sriuranpong; Chong Jen Yu; Sumitra Thongprasert; Jennifer Sandoval-Tan; Jin Soo Lee; Fatima Fuerte; David S. Shames; Barbara Klughammer; Matt Truman; Pablo Perez-Moreno; Yi Long Wu

Showing results 1 to 5 of 5